Mature companies are increasingly injecting fresh blood into themselves through the establishment of incubators, and Fosun Pharma has to do the same. Recently, Fosun Pharma announced the establishment of a technology innovation incubation platform to find, discover and cultivate innovative projects on a global scale, with a focus on precision medicine, regenerative medicine, artificial intelligence and other fields. The incubation platform will operate in a fund management company model with an investment period of 9 years, but may be extended or shortened depending on the situation. The investment amount of Fosun Pharma does not exceed RMB 500 million. Professor Xu Tian, ​​the company's partner and deputy department head of the Department of Genetics at Yale University, is solely responsible for the overall operation and management of the incubation platform. Unlike Fosun's past incubation projects, this platform with a “deep incubation†model targets a larger number of projects, longer cycles, and more advanced areas. “In the past, our investment methods were mainly two. One was the merger or joint venture of mature enterprises, and the other was the VC fund-type small equity investment model.†Chen Qiyu, chairman of Fosun Pharma, told reporters, “This new incubation platform is geared toward Unknown technology, we will use Professor Xu Tian's global academic knowledge and scientific attainments in the fields of life sciences, medicine, artificial intelligence, etc., as well as the in-depth operational capabilities of Fosun Pharma's industry, looking for the next 5-10 years or even 15 years in the world. There will be explosive technology." According to Prof. Xu Tian, ​​these possible “explosive technologiesâ€, according to Professor Xu Tian, ​​will focus on three frontier areas: the combination of artificial intelligence and biomedicine (such as the use of artificial intelligence for new drug development), stem cells and genes. Treatment, synthetic biology (detection of drug genes by sequencing, and the use of yeast to synthesize drugs, can be used for the synthesis of traditional Chinese medicine such as artemisinin). The establishment of a new incubation platform means that Fosun Pharma is carrying out a more front-end and more systematic layout in this battle for innovation. Soy lecithin powder is a substance derived from soybeans that is commonly used as an emulsifier, stabilizer, and thickener in food products. It is a natural source of phospholipids, which are essential components of cell membranes. Soy lecithin powder is often added to chocolate, baked goods, and other processed foods to improve texture and prevent separation of ingredients. It is also used in the production of dietary supplements and pharmaceuticals. Soy lecithin powder is generally considered safe for consumption, although some people with soy allergies may need to avoid it. Soy Lecithin Powder,Soya Lecithin Powder,Soybean Powder,Soybean Lecithin Powder Jiangsu Chenwei Biology and Technology Co. LTD , https://www.cwsoybean.com